Zemlan FP

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group - Zemlan_1996_J.Neural.Transm.(Vienna)_103_1105
Author(s) : Zemlan FP
Ref : J Neural Transm (Vienna) , 103 :1105 , 1996
Abstract : Zemlan_1996_J.Neural.Transm.(Vienna)_103_1105
ESTHER : Zemlan_1996_J.Neural.Transm.(Vienna)_103_1105
PubMedSearch : Zemlan_1996_J.Neural.Transm.(Vienna)_103_1105
PubMedID: 9013398

Title : Double-blind placebo-controlled study of velnacrine in Alzheimer's disease - Zemlan_1996_Life.Sci_58_1823
Author(s) : Zemlan FP , Keys M , Richter RW , Strub RL
Ref : Life Sciences , 58 :1823 , 1996
Abstract : Zemlan_1996_Life.Sci_58_1823
ESTHER : Zemlan_1996_Life.Sci_58_1823
PubMedSearch : Zemlan_1996_Life.Sci_58_1823
PubMedID: 8637408